Year: 2023
Type: article
Abstract: Obstructive sleep apnea (OSA) in children is a prevalent, but still, today, underdiagnosed illness, which consists of repetitive episodes of upper airway obstruction during sleep with important repercussions for sleep quality. OSA has relevant consequences in the pediatric population, mainly in the metabolic, cardiovascular (CV), and neurological spheres. However, contrary to adults, advances in diagnostic and therapeutic management have been scarce in the last few years despite the increasing scientific evidence of the deleterious consequences of pediatric OSA. The problem of underdiagnosis and the lack of response to treatment in some groups make an update to the management of OSA in children necessary. Probably, the heterogeneity of OSA is not well represented by the classical clinical presentation and severity parameters (apnea/hypopnea index (AHI)), and new strategies are required. A specific and consensus definition should be established. Additionally, the role of simplified methods in the diagnosis algorithm should be considered. Finally, the search for new biomarkers for risk stratification is needed in this population. In conclusion, new paradigms based on personalized medicine should be implemented in this population.
Source: Biomedicines
Institutions: Hospital Universitario de Guadalajara, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Universidad de Alcalá, Laboratoire Interdisciplinaire des Énergies de Demain, Centre d'études sociologiques et politiques Raymond-Aron, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, Universitat de Lleida, Hospital Universitari Arnau de Vilanova, Instituto de Investigación Biomédica de Lleida, Hospital Universitario La Paz, Hospital La Paz Institute for Health Research, Universidad Autónoma de Madrid
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,447
Awards: G2135104406, G2180432602, G5149896999, Valoración de la prevalencia de Hipertensión Arterial en paciente pediátricos con Trastornos Respiratorios del Sueño. Reversibilidad de la misma tras el tratamiento. The KIDS TRIAL STUDY., G7062737235, G7410071769, G7863468062, Impacto de la Apnea Obstructiva del Sueño en la detección precoz y progresión de la aterosclerosis subclínica como marcador de riesgo cardiovascular futuro. PESA-H-Sueño.
OpenAlex ID: W4380686352
